-
Mashup Score: 0Coronavirus (COVID-19) | ASCO Publications - 3 year(s) ago
…
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
Many developing countries in Latin America have experienced increasing prostate cancer (Pca) trends from 1993 to 2002, and some countries have reported an increase in mortality rates. The same trend appears to be happening worldwide. In this context, the first Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) was…
Source: JCO Global OncologyCategories: Latest Headlines, Oncologists2Tweet-
RT @JCOGO_ASCO: #JCOGO Speical Series: GU malignancies in low & middle-income countries https://t.co/M4z8VaGI4M #prostatecancer #pcsm #glob…
-
-
Mashup Score: 5Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial - 3 year(s) ago
PURPOSE We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND METHODS A randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Article Processing Charge Waiver Policies as a Barrier to Oncology Scholarship in Low- and Lower-Middle-Income Countries - 3 year(s) ago
Open access (OA) publication aims to increase transparency and reproducibility in scientific research, thereby providing equal access to discovery and knowledge.1 Moreover, OA publishing allows innovative research to reach a global audience without additional cost to consumers.2 The importance of accessibility through OA has been made particularly evident in the worldwide rapid sharing of…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America - 3 year(s) ago
PURPOSE We present a physician survey of the impact of 21-gene Breast Recurrence Score test results on treatment decisions in clinical practice in Latin America. METHODS This prospective survey enrolled consecutive patients at 14 sites in Argentina, Colombia, Mexico, and Peru who had routine 21-gene testing. Physician surveys captured patient and tumor characteristics and treatment decisions…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials - 3 year(s) ago
Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Breast Cancer Early Detection in Eswatini: Evaluation of a Training Curriculum and Patient Receipt of Recommended Follow-Up Care - 3 year(s) ago
A breast cancer early detection program in Eswatini using clinical breast exam improved nurses’ evaluation skills.
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
PURPOSE The National Cancer Information System (NCIS) has been operating since 2014, including information reported by health care insurers and providers on people with cancer diagnosed and treated within the Colombian health system. Its main purpose is to identify barriers to an effective access to cancer diagnosis and treatment across the country. We aimed to describe the methodology, scope and…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced - 3 year(s) ago
In 2018, the United States Preventive Services Task Force issued a final recommendation for primary screening of cervical cancer using human papillomavirus (HPV) testing either alone or in combination with cytologic screening in women older than age 30 years. Since then, several agencies including the WHO and the American Cancer Society have echoed the use of HPV testing as the preferred primary…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns - 3 year(s) ago
PURPOSE Breast cancer is the most common malignancy in Brazilian women, with 66,280 new cases in 2020 (with 20% overexpressing human epidermal growth factor receptor 2 [HER2]). The trastuzumab biosimilar was the first oncology biosimilar approved in Brazil for HER2-positive breast cancer treatment. This study aimed to assess the current level of knowledge of biosimilars, comfort of use,…
Source: JCO Global OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Our journals make it easy to find the latest published research on #COVID19 and #cancer. Check it out ➡️ https://t.co/3fIuBRlkoV #COVID19nCancer #JCO #JCOOP #JCOGO #JCOPO #JCOCCI https://t.co/nRuddQvMyq